DNA Microarray Industry Insights: Market Forecast to 2029

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

How Much Larger Is The DNA Microarray Market Expected To Become By 2029 Compared With Its 2025 Level?

The dna microarray market has experienced swift expansion recently. Forecasts indicate it will expand from $3.38 billion in 2024 to reach $3.78 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 11.9%. Historically, this growth has stemmed from factors such as pharmacogenomics, advancements in healthcare infrastructure, strategic collaborations and partnerships, efforts to reduce costs, and increased public awareness and education.

The dna microarray market size is projected to experience substantial growth in the upcoming years, with an anticipated rise to $5.82 billion by 2029, reflecting a compound annual growth rate (CAGR) of 11.4%. This expansion throughout the forecast period is attributable to factors such as the increasing development of personalized medicine, the emergence of comparative genomic hybridization (CGH), the broadening of agricultural genomics applications, the implementation of regulatory approvals and standards, and the increasing prevalence of chronic diseases. Prominent trends expected in the forecast period include ongoing advancements in genomic research, increased funding allocated to genomic studies, significant technological innovations, deeper integration with other technologies, and continuous technological advancements.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=16039&type=smp

Which Factors And Drivers Are Influencing The DNA Microarray Market In 2025?

The quick embrace of personalized medicine is projected to fuel the expansion of the DNA microarray market. Personalized medicine involves customizing medical treatments for individual patients, taking into account their genetic, environmental, and lifestyle elements to enhance therapeutic effectiveness and results. Its emergence is attributed to the swift advancements in ‘omics’ technology, data integration, genetics, and a heightened understanding of the importance of customized patient-specific drugs and preventative strategies. DNA microarrays facilitate personalized medicine through the analysis of gene expression patterns, enabling the creation of customized treatment regimens aligned with an individual’s genetic makeup. As an illustration, in February 2024, the Personalized Medicine Coalition, a US-based non-profit organization, reported that the FDA approved 16 new personalized therapies for rare disease patients in 2023, which is significantly more than the 6 approved in 2022. Consequently, the swift uptake of personalized medicine is acting as a key driver for the DNA microarray market.

How Is The DNA Microarray Market Segmented?

The dna microarraymarket covered in this report is segmented –

1) By Type: Complementary DNA Microarrays; Oligonucleotide DNA Microarrays; Other Types

2) By Application: Gene Expression Analysis; Genotyping; Other Applications

3) By End-user: Pharmaceutical And Biotechnology Companies; Diagnostic Centers; Hospitals And Clinics; Academic And Research Institute; Other End-Users

Subsegments:

1) By Complementary DNA Microarrays: Gene Expression Profiling; Comparative Genomic Hybridization (CGH); Quantitative Analysis

2) By Oligonucleotide DNA Microarrays: Gene Expression Microarrays; Single Nucleotide Polymorphism (SNP) Arrays; DNA Methylation Arrays; Pathogen Detection Arrays

3) By Other Types: Protein-DNA Microarrays; Tissue Microarrays; Affinity Microarrays; Spotted DNA Microarrays

How Are Emerging Market Trends Shaping The DNA Microarray Industry Landscape?

Major companies within the DNA microarray market are prioritizing the creation of advanced technology that offers a two-day turnaround time to secure a competitive advantage. Microarray analysis provides results within two days, ensuring their swiftness and efficiency. This rapid processing significantly accelerates both research and clinical decision-making processes. For instance, in August 2023, Thermo Fisher Scientific Inc., a US-based biotechnology company, unveiled the Applied Biosystems CytoScan HD Accel array. This new chromosomal microarray aims to elevate productivity, efficiency, and profitability in cytogenetic research laboratories, featuring a leading two-day turnaround time. The CytoScan HD Accel array conducts whole-genome analysis with enhanced coverage across more than 5,000 key genomic regions, furnishing insights into chromosomal variants for diverse applications in prenatal, postnatal, and oncology research.

Which Leading Companies Dominate The DNA Microarray Market Share?

Major companies operating in the DNA microarray market are Roche Holding AG, Thermo Fisher Scientific Inc., Danaher Corporation, Merck KGaA, Agilent Technologies Inc., PerkinElmer Inc., Illumina Inc., bioMérieux SA, Schott AG, Bio-Rad Laboratories Inc., QIAGEN N.V., Bioneer Corporation, CapitalBio Technology Co. Ltd., Eurofins Genomics LLC, Savyon Diagnostics Ltd., Oxford Gene Technology, Sengenics Corporation LLC, Affymetrix, BioCat GmbH, Scienion AG, LC Sciences, Arrayit Corporation, Akonni Biosystems Inc., Arraystar Inc., Febit Holding GmbH

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/dna-microarray-global-market-report

Which Regional Markets Are Contributing Most To The DNA Microarray Industry Expansion?

North America was the largest region in the DNA microarray market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the DNA microarray market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Version Of The DNA Microarray Market Report:

https://www.thebusinessresearchcompany.com/customise?id=16039&type=smp

Browse Through More Reports Similar to the Global DNA Microarray Market 2025, By The Business Research Company

Dna Based Skin Care Products Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/dna-based-skin-care-products-global-market-report

Dna And Gene Chip Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/dna-and-gene-chip-global-market-report

Recombinant Dna Technology Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/recombinant-dna-technology-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795